Men Are Going to Strike Back
Wait, That's Why Dems Are Scared About ICE Agents Wearing Body Cams
Bill Maher Had the Perfect Response to Billie Eilish's 'Stolen Land' Nonsense
Some Guy Wanted to Test Something at an Anti-ICE Rally. Their Reaction Says...
The Trump Team Quoted the Perfect TV Show to Defend a Proposed WH...
Why This Former CNN Reporter Saying He'd Fire Scott Jennings Is Amusing
Democrats Have Earned All the Bad Things
Don Lemon Plays Civil Rights Martyr After Cities Church Mob Arrest
Canadian PM Carney Just Announced a Plan to Make Canadian Inflation Worse
CA Governor Election 2026: Bianco or Hilton
Same Old, Same Old
The Real Purveyors of Jim Crow
Senior Voters Are Key for a GOP Victory in Midterms
The Deep State’s Inversion Matrix Must Be Seen to Be Defeated
Situational Science and Trans Medicine
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement